Cargando…
Disparate effects of single endothelin A and B receptor blocker therapy on the progression of renal injury in advanced renovascular disease
We hypothesized that chronic specific endothelin (ET)-A receptor blockade therapy would reverse renal dysfunction and injury in advanced experimental renovascular disease. To test this, unilateral renovascular disease was induced in 19 pigs and after 6 weeks, single-kidney hemodynamics and function...
Autores principales: | Chade, Alejandro R., Stewart, Nicholas J., Peavy, Patrick R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972340/ https://www.ncbi.nlm.nih.gov/pubmed/24352153 http://dx.doi.org/10.1038/ki.2013.477 |
Ejemplares similares
-
Understanding and managing atherosclerotic renovascular disease: still a work in progress
por: Chade, Alejandro R.
Publicado: (2018) -
Endotheliitis, endothelin, and endothelin receptor blockers in COVID-19
por: Sanghavi, Devang K., et al.
Publicado: (2021) -
Renal autoregulation in medical therapy of renovascular hypertension
por: Lubas, Arkadiusz, et al.
Publicado: (2010) -
Renovascular Hypertension Treated by Renal Artery Embolization
por: Lee, Jeong Ju, et al.
Publicado: (2014) -
Endothelin A receptor blocker and calcimimetic in the adenine rat model of chronic renal insufficiency
por: Törmänen, Suvi, et al.
Publicado: (2017)